VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HIT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HITHealth In Tech, Inc.
$1.01$54M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHITBalance Sheet

Health In Tech, Inc. (HIT) Balance Sheet

4Y historyFree accessUpdated daily

The company maintains a conservative capital structure with a debt-to-equity ratio of 0.01 as of 2026Q1, providing a solid foundation despite the rapid expansion of total assets to $29.0 million.

HIT Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22
Total Current Assets22.09M16.16M10.78M6.86M25.43M
Cash & Short-Term Investments10.33M7.67M7.85M2.42M1.49M
Cash Only10.33M7.67M7.85M2.42M1.49M
Short-Term Investments00000
Accounts Receivable3.74M756.29K2.15M3.92M976.86K
Days Sales Outstanding38.478.2840.2174.6561.8
Inventory00000
Days Inventory Outstanding-----
Other Current Assets8.02M7.73M787.16K526.15K22.96M
Total Non-Current Assets6.88M6.93M4.98M4.64M3.13M
Property, Plant & Equipment122.33K139.94K206.27K266.64K321.81K
Fixed Asset Turnover229.80x238.16x94.49x71.83x17.93x
Goodwill00000
Intangible Assets003.96M3.56M2.76M
Long-Term Investments00000
Other Non-Current Assets6.76M6.79M816K816K48.23K
Total Assets28.97M23.09M15.77M11.5M28.56M
Asset Turnover1.41x1.44x1.24x1.66x0.20x
Asset Growth %323.54%46.43%37.08%-59.72%-
Total Current Liabilities7.05M5.16M2.13M4.78M24.02M
Accounts Payable001.86M2.62M474.39K
Days Payables Outstanding56.23-167.47415.23518.13
Short-Term Debt78.68K76.19K01.65M0
Deferred Revenue (Current)00000
Other Current Liabilities6.97M5.08M0023.37M
Current Ratio3.13x3.13x5.06x1.43x1.06x
Quick Ratio3.13x3.13x5.06x1.43x1.06x
Cash Conversion Cycle-17.76----
Total Non-Current Liabilities316.12K821.29K468.49K628.67K3.12M
Long-Term Debt42.91K63.62K000
Capital Lease Obligations186.77K0139.81K206.69K265.37K
Deferred Tax Liabilities1.57M757.67K328.68K421.98K288K
Other Non-Current Liabilities00002.57M
Total Liabilities7.36M5.98M2.6M5.41M27.14M
Total Debt121.59K139.81K206.69K1.92M316.09K
Net Debt-10.2M-7.53M-7.64M-501.18K-1.17M
Debt / Equity0.01x0.01x0.02x0.31x0.22x
Debt / EBITDA2.11x0.06x0.14x0.51x1.54x
Net Debt / EBITDA-176.88x-3.10x-4.99x-0.13x-5.70x
Interest Coverage--2.80x1668.59x44.97x
Total Equity21.6M17.11M13.17M6.09M1.42M
Equity Growth %382.34%29.94%116.13%329.62%-
Book Value per Share0.380.300.250.110.03
Total Shareholders' Equity21.6M17.11M13.17M6.09M1.05M
Common Stock65.56K57.71K54.62K51.77K45K
Retained Earnings3.63M5.22M3.94M3.27M794.26K
Treasury Stock00000
Accumulated OCI00000
Minority Interest0000367.77K

Key Metrics

Growth RegimeExpanding
ProfitabilityStrained
Balance SheetAdequate
Cash FlowDeteriorating
Top Statement Risk

Liquidity constraints from scaling

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Balance Sheet Expansion Amidst Scaling

According to the provided quarterly balance sheets, total assets grew from $11.5 million in 2023Q4 to $29.0 million by 2026Q1, reflecting a rapid expansion phase that appears to be driven by aggressive investment in the company's proprietary eDIYBS quoting engine and broader market penetration efforts.

The consistent growth in total assets suggests that the company is successfully deploying capital to scale its infrastructure, though this trajectory is increasingly reliant on external funding or retained earnings. Investors should monitor whether this asset growth translates into sustainable long-term competitive advantages or if it merely reflects the high cost of maintaining a complex, service-heavy insurance platform.

Minimal Leverage Supports Financial Flexibility

Based on reported financial statements, the company maintains a conservative capital structure with a debt-to-equity ratio of 0.01% as of 2026Q1, indicating that management has largely avoided debt-based financing to fund its rapid growth, thereby preserving significant balance sheet flexibility for future operational needs.

The near-zero debt profile suggests that the firm is currently prioritizing equity-based growth, which mitigates immediate refinancing risks but may limit the company's ability to leverage its balance sheet for inorganic expansion. This reliance on equity suggests that shareholders should remain cautious regarding potential dilution if the company requires additional capital to sustain its current growth trajectory.

Liquidity Buffer Faces Scaling Pressure

As reported in recent filings, the current ratio has fluctuated significantly, settling at 3.13 in 2026Q1, which provides a temporary liquidity buffer, yet the absolute cash position of $10.3 million may prove insufficient if the current rate of cash burn continues to accelerate alongside operational expansion.

While the current ratio appears healthy on the surface, the underlying cash position relative to the company's aggressive growth strategy warrants close scrutiny. The volatility in liquidity metrics suggests that the firm's ability to meet short-term obligations could be tested if revenue growth fails to offset the rising costs of claims advocacy and network management.

Equity Quality and Capitalization Trends

Based on the provided data, equity has increased from $6.1 million in 2023Q4 to $21.6 million in 2026Q1, a trend that appears to be driven by the accumulation of retained earnings and potential capital injections, though the quality of this equity remains subject to future operational performance.

The growth in equity provides a solid foundation for the company's ongoing operations, yet the reliance on retained earnings to bolster the balance sheet implies that profitability is critical for long-term stability. Analysts should monitor whether future equity growth is driven by organic earnings or if the company will need to rely on further share issuance to maintain its current pace.

HIT — Frequently Asked Questions

Quick answers to the most common questions about buying HIT stock.

What are the total assets of Health In Tech, Inc. (HIT)?

As of 2025, Health In Tech, Inc. (HIT) had total assets of $23.1M including $16.2M in current assets.

How much debt does Health In Tech, Inc. (HIT) have?

Health In Tech, Inc. (HIT) carries total debt of $0.1M, offset by $7.7M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Health In Tech, Inc.?

Health In Tech, Inc. (HIT) has total shareholders' equity (book value) of $17.1M ($0.30 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Health In Tech, Inc.'s current ratio and liquidity?

Health In Tech, Inc. (HIT) reported a current ratio of 3.13x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.